MT-4561

· Tanabe Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-4561, covering 2025-12-11 to 2025-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MT-4561 in Patients With Various Advanced Solid Tumors [Phase 1, Phase 2]